Description
A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat receptors, respectively); blocks agonist-induced IL-1β release and pore formation in differentiated THP-1 cells (IC50s = 156 and 92 nM, respectively); effective in vivo when administered intraperitoneally
Formal name: N-[1-[[(cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxy-benzeneacetamide
Synonyms:
Molecular weight: 474.6
CAS: 861393-28-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Neuroscience|Pain Research